138 related articles for article (PubMed ID: 31698822)
1. Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK).
Asquith CRM; Bennett JM; Su L; Laitinen T; Elkins JM; Pickett JE; Wells CI; Li Z; Willson TM; Zuercher WJ
Molecules; 2019 Nov; 24(22):. PubMed ID: 31698822
[TBL] [Abstract][Full Text] [Related]
2. The cyclin G-associated kinase (GAK) inhibitor SGC-GAK-1 inhibits neurite outgrowth and synapse formation.
Egawa J; Arta RK; Lemmon VP; Muños-Barrero M; Shi Y; Igarashi M; Someya T
Mol Brain; 2022 Jul; 15(1):68. PubMed ID: 35883152
[TBL] [Abstract][Full Text] [Related]
3. SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK).
Asquith CRM; Berger BT; Wan J; Bennett JM; Capuzzi SJ; Crona DJ; Drewry DH; East MP; Elkins JM; Fedorov O; Godoi PH; Hunter DM; Knapp S; Müller S; Torrice CD; Wells CI; Earp HS; Willson TM; Zuercher WJ
J Med Chem; 2019 Mar; 62(5):2830-2836. PubMed ID: 30768268
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Water Network in Cyclin G-Associated Kinase (GAK) with 4-Anilino-quin(az)oline Inhibitors.
Asquith CRM; Tizzard GJ; Bennett JM; Wells CI; Elkins JM; Willson TM; Poso A; Laitinen T
ChemMedChem; 2020 Jul; 15(13):1200-1215. PubMed ID: 32358915
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase.
Martinez-Gualda B; Saul S; Froeyen M; Schols D; Herdewijn P; Einav S; De Jonghe S
Eur J Med Chem; 2021 Mar; 213():113158. PubMed ID: 33497888
[TBL] [Abstract][Full Text] [Related]
6. Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase.
Asquith CRM; Laitinen T; Bennett JM; Godoi PH; East MP; Tizzard GJ; Graves LM; Johnson GL; Dornsife RE; Wells CI; Elkins JM; Willson TM; Zuercher WJ
ChemMedChem; 2018 Jan; 13(1):48-66. PubMed ID: 29072804
[TBL] [Abstract][Full Text] [Related]
7. A Scaffold-Hopping Strategy toward the Identification of Inhibitors of Cyclin G Associated Kinase.
Wouters R; Tian J; Herdewijn P; De Jonghe S
ChemMedChem; 2019 Jan; 14(2):237-254. PubMed ID: 30548533
[TBL] [Abstract][Full Text] [Related]
8. Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.
Pu SY; Wouters R; Schor S; Rozenski J; Barouch-Bentov R; Prugar LI; O'Brien CM; Brannan JM; Dye JM; Herdewijn P; De Jonghe S; Einav S
J Med Chem; 2018 Jul; 61(14):6178-6192. PubMed ID: 29953812
[TBL] [Abstract][Full Text] [Related]
9. Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents.
Kovackova S; Chang L; Bekerman E; Neveu G; Barouch-Bentov R; Chaikuad A; Heroven C; Šála M; De Jonghe S; Knapp S; Einav S; Herdewijn P
J Med Chem; 2015 Apr; 58(8):3393-410. PubMed ID: 25822739
[TBL] [Abstract][Full Text] [Related]
10. Utilizing comprehensive and mini-kinome panels to optimize the selectivity of quinoline inhibitors for cyclin G associated kinase (GAK).
Asquith CRM; Treiber DK; Zuercher WJ
Bioorg Med Chem Lett; 2019 Jul; 29(14):1727-1731. PubMed ID: 31129055
[TBL] [Abstract][Full Text] [Related]
11. Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines.
Wouters R; Pu SY; Froeyen M; Lescrinier E; Einav S; Herdewijn P; De Jonghe S
Eur J Med Chem; 2019 Feb; 163():256-265. PubMed ID: 30529544
[TBL] [Abstract][Full Text] [Related]
12. Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies.
Chaikuad A; Keates T; Vincke C; Kaufholz M; Zenn M; Zimmermann B; Gutiérrez C; Zhang RG; Hatzos-Skintges C; Joachimiak A; Muyldermans S; Herberg FW; Knapp S; Müller S
Biochem J; 2014 Apr; 459(1):59-69. PubMed ID: 24438162
[TBL] [Abstract][Full Text] [Related]
13. Potent bicyclic inhibitors of malarial cGMP-dependent protein kinase: approaches to combining improvements in cell potency, selectivity and structural novelty.
Large JM; Birchall K; Bouloc NS; Merritt AT; Smiljanic-Hurley E; Tsagris DJ; Wheldon MC; Ansell KH; Coombs PJ; Kettleborough CA; Whalley D; Stewart LB; Bowyer PW; Baker DA; Osborne SA
Bioorg Med Chem Lett; 2019 Oct; 29(19):126610. PubMed ID: 31471167
[TBL] [Abstract][Full Text] [Related]
14. Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia.
Liu X; Wang B; Chen C; Jiang Z; Hu C; Wu H; Zhang Y; Liu X; Wang W; Wang J; Hu Z; Wang A; Huang T; Liu Q; Wang W; Wang L; Wang W; Ren T; Li L; Xia R; Ge J; Liu Q; Liu J
Eur J Med Chem; 2018 Dec; 160():61-81. PubMed ID: 30317026
[TBL] [Abstract][Full Text] [Related]
15. Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479.
Robarge KD; Lee W; Eigenbrot C; Ultsch M; Wiesmann C; Heald R; Price S; Hewitt J; Jackson P; Savy P; Burton B; Choo EF; Pang J; Boggs J; Yang A; Yang X; Baumgardner M
Bioorg Med Chem Lett; 2014 Oct; 24(19):4714-4723. PubMed ID: 25193232
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity relationships.
Wang Y; Liu WJ; Yin L; Li H; Chen ZH; Zhu DX; Song XQ; Cheng ZZ; Song P; Wang Z; Li ZG
Bioorg Med Chem Lett; 2018 Mar; 28(5):974-978. PubMed ID: 29429832
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of anticoccidial agents: 5,6-diarylimidazo[2,1-b][1,3]thiazoles.
Scribner A; Meitz S; Fisher M; Wyvratt M; Leavitt P; Liberator P; Gurnett A; Brown C; Mathew J; Thompson D; Schmatz D; Biftu T
Bioorg Med Chem Lett; 2008 Oct; 18(19):5263-7. PubMed ID: 18789686
[TBL] [Abstract][Full Text] [Related]
18. Multiple roles for cyclin G-associated kinase in clathrin-mediated sorting events.
Zhang CX; Engqvist-Goldstein AE; Carreno S; Owen DJ; Smythe E; Drubin DG
Traffic; 2005 Dec; 6(12):1103-13. PubMed ID: 16262722
[TBL] [Abstract][Full Text] [Related]
19. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase.
Kousba A; Soll R; Yee S; Martin M
Drug Metab Dispos; 2007 Dec; 35(12):2242-51. PubMed ID: 17881660
[TBL] [Abstract][Full Text] [Related]
20. GAK: a cyclin G associated kinase contains a tensin/auxilin-like domain.
Kanaoka Y; Kimura SH; Okazaki I; Ikeda M; Nojima H
FEBS Lett; 1997 Jan; 402(1):73-80. PubMed ID: 9013862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
